2 Scopus citations


A number of innovations in the treatment of advanced non-Hodgkin's lymphoma have emerged in the last 20 years, one of which is the use of combination protocols formerly reserved for the treatment of patients with Hodgkin's disease. These regimens, employing a wide variety of antineoplastic agents in combination, show promise for improving survival rates for varying lenghts of time. Other approaches - such as intensification of therapy; the addition of mitoxantrone to the oncologist's armamentarium; high-dose therapy with transplantation; and the use of hematopoietic growth factors, biologic response modifiers, and monoclonal antibodies - hold much promise for further advances.

Original languageEnglish (US)
Pages (from-to)564-570
Number of pages7
JournalHospital Formulary
Issue number7
StatePublished - 1991

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'New approaches to therapy in patients with lymphoma'. Together they form a unique fingerprint.

Cite this